Literature DB >> 21233209

Cyclin-cyclin-dependent kinase regulatory response is linked to substrate recognition.

Maria Emanuela Cuomo1, Georgina M Platt, Laurence H Pearl, Sibylle Mittnacht.   

Abstract

Cyclin/cyclin-dependent kinase (CDK) complexes are critical regulators of cellular proliferation. A complex network of regulatory mechanisms has evolved to control their activity, including activating and inactivating phosphorylation of the catalytic CDK subunit and inhibition through specific regulatory proteins. Primate herpesviruses, including the oncogenic Kaposi sarcoma herpesvirus, encode cyclin D homologues. Viral cyclins have diverged from their cellular progenitor in that they elicit holoenzyme activity independent of activating phosphorylation by the CDK-activating kinase and resistant to inhibition by CDK inhibitors. Using sequence comparison and site-directed mutagenesis, we performed molecular analysis of the cellular cyclin D and the Kaposi sarcoma herpesvirus-cyclin to delineate the molecular mechanisms behind their different behavior. This provides evidence that a surface recognized for its involvement in the docking of CIP/KIP inhibitors is required and sufficient to modulate cyclin-CDK response to a range of regulatory cues, including INK4 sensitivity and CDK-activating kinase dependence. Importantly, amino acids in this region are critically linked to substrate selection, suggesting that a mutational drift in this surface simultaneously affects function and regulation. Together our work provides novel insight into the molecular mechanisms governing cyclin-CDK function and regulation and defines the biological forces that may have driven evolution of viral cyclins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233209      PMCID: PMC3059039          DOI: 10.1074/jbc.M110.173872

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F.

Authors:  Y P Chew; M Ellis; S Wilkie; S Mittnacht
Journal:  Oncogene       Date:  1998-10-29       Impact factor: 9.867

Review 2.  Control of pRB phosphorylation.

Authors:  S Mittnacht
Journal:  Curr Opin Genet Dev       Date:  1998-02       Impact factor: 5.578

3.  Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.

Authors:  S W Blain; E Montalvo; J Massagué
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

Review 4.  Cyclin-dependent kinases: engines, clocks, and microprocessors.

Authors:  D O Morgan
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

Review 5.  Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV.

Authors:  P S Moore; Y Chang
Journal:  Trends Genet       Date:  1998-04       Impact factor: 11.639

6.  The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1.

Authors:  D Godden-Kent; S J Talbot; C Boshoff; Y Chang; P Moore; R A Weiss; S Mittnacht
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

7.  Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.

Authors:  B A Schulman; D L Lindstrom; E Harlow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex.

Authors:  M Ellis; Y P Chew; L Fallis; S Freddersdorf; C Boshoff; R A Weiss; X Lu; S Mittnacht
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

9.  Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d.

Authors:  D H Brotherton; V Dhanaraj; S Wick; L Brizuela; P J Domaille; E Volyanik; X Xu; E Parisini; B O Smith; S J Archer; M Serrano; S L Brenner; T L Blundell; E D Laue
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

10.  Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a.

Authors:  A A Russo; L Tong; J O Lee; P D Jeffrey; N P Pavletich
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.